LoginRegister
    Foamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acneFoamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acne
    Alexion Pharma to acquire clinical-stage biopharmaceutical firm AchillionAlexion Pharma to acquire clinical-stage biopharmaceutical firm Achillion
    CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drugCDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug
    Jubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCDJubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCD
    Novartis boosts 2019 forecasts as Cosentyx, Zolgensma shineNovartis boosts 2019 forecasts as Cosentyx, Zolgensma shine
    Strides Pharma reports revenue of Rs 718 crore for Q2Strides Pharma reports revenue of Rs 718 crore for Q2
    Alexion Ultomiris gets USFDA approval for treating another rare blood diseaseAlexion Ultomiris gets USFDA approval for treating another rare blood disease
    Biogen in consultation with USFDA plans regulatory filing for AD drug AducanumabBiogen in consultation with USFDA plans regulatory filing for AD drug Aducanumab
    Dr Reddys gets CDSCO Committee recommendation for approval for additional indications of DesosumabDr Reddys gets CDSCO Committee recommendation for approval for additional indications of Desosumab
    Shilpa Medicare Telangana facility gets EIR from USFDAShilpa Medicare Telangana facility gets EIR from USFDA
    Aurobindo Pharma wins USFDA nod for generic version of Mucinex TabletsAurobindo Pharma wins USFDA nod for generic version of Mucinex Tablets
    AstraZeneca new drugs including Tagrisso, Lynparza boost Q3 product salesAstraZeneca new drugs including Tagrisso, Lynparza boost Q3 product sales
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X